The most powerful supercomputer in Britain which will be used to study various diseases is now operational.
Christened Cambridge-1 is a $ 100 million investment from Nvidia and puts artificial intelligence and big data to work.
The first project of the supercomputer will be to analyze diseases such as dementia, create new medicines and find the causes of various diseases with higher accuracy.
In the field of immuno-oncology, existing cures use the human immune system to fight cancer. But in some patients these cures do not give the same effect as in some others. Cambridge-1 will build extensive models of treatments that also determine the best treatment for specific patients.
Developing courses in the traditional way is very costly and has a small chance of success. Technology is still in its infancy and its potential could be much higher than scientists today think. / PCWorld Albanian
